136 related articles for article (PubMed ID: 38084551)
21.
Wang L; Wang W; Beird HC; Cheng X; Fang H; Tang G; Toruner GA; Yin CC; You MJ; Issa GC; Borthakur G; Peng G; Khoury JD; Medeiros LJ; Tang Z
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011278
[TBL] [Abstract][Full Text] [Related]
22. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
[TBL] [Abstract][Full Text] [Related]
23. Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia.
Corbacioglu A; Scholl C; Schlenk RF; Eiwen K; Du J; Bullinger L; Fröhling S; Reimer P; Rummel M; Derigs HG; Nachbaur D; Krauter J; Ganser A; Döhner H; Döhner K
J Clin Oncol; 2010 Aug; 28(23):3724-9. PubMed ID: 20625124
[TBL] [Abstract][Full Text] [Related]
24. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
[TBL] [Abstract][Full Text] [Related]
25. [Acute myeloid leukemia with type I CBFB::MYH11 fusion gene not detected by screening test for leukemia-related chimeric genes].
Utsumi S; Shima T; Kubara C; Semba Y; Hayashi M; Takigawa K; Yoshino T; Minami M; Matsuo Y; Kuriyama T; Akashi K; Maeda T; Taniguchi S; Eto T
Rinsho Ketsueki; 2023; 64(12):1503-1507. PubMed ID: 38220149
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
Kobayashi T; Ichikawa M; Kamikubo Y; Kurokawa M
Int J Clin Exp Pathol; 2013; 6(1):110-2. PubMed ID: 23236551
[TBL] [Abstract][Full Text] [Related]
27. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11.
Kundu M; Chen A; Anderson S; Kirby M; Xu L; Castilla LH; Bodine D; Liu PP
Blood; 2002 Oct; 100(7):2449-56. PubMed ID: 12239155
[TBL] [Abstract][Full Text] [Related]
28. Incidental identification of inv(16)(p13.1q22)/
Quesada AE; Luthra R; Jabbour E; Patel KP; Khoury JD; Tang Z; Alvarez H; Mallampati S; Garcia-Manero G; Montalban-Bravo G; Medeiros LJ; Kanagal-Shamanna R
Cold Spring Harb Mol Case Stud; 2021 Jun; 7(3):. PubMed ID: 34117074
[TBL] [Abstract][Full Text] [Related]
29. Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.
Opatz S; Polzer H; Herold T; Konstandin NP; Ksienzyk B; Zellmeier E; Vosberg S; Graf A; Krebs S; Blum H; Hopfner KP; Kakadia PM; Schneider S; Dufour A; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK; Greif PA
Blood; 2013 Sep; 122(10):1761-9. PubMed ID: 23878140
[TBL] [Abstract][Full Text] [Related]
30. RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML.
Hyde RK; Liu P; Friedman AD
Adv Exp Med Biol; 2017; 962():265-282. PubMed ID: 28299663
[TBL] [Abstract][Full Text] [Related]
31. Prognostic values of D816V KIT mutation and peri-transplant CBFB-MYH11 MRD monitoring on acute myeloid leukemia with CBFB-MYH11.
Cho BS; Min GJ; Park SS; Park S; Jeon YW; Shin SH; Yahng SA; Yoon JH; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim M; Kim Y; Kim HJ
Bone Marrow Transplant; 2021 Nov; 56(11):2682-2689. PubMed ID: 34183780
[TBL] [Abstract][Full Text] [Related]
32. 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop.
Slovak ML; Bedell V; Popplewell L; Arber DA; Schoch C; Slater R
Genes Chromosomes Cancer; 2002 Apr; 33(4):379-94. PubMed ID: 11921272
[TBL] [Abstract][Full Text] [Related]
33. Myeloid Sarcoma With CBFB-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
Dalland JC; Meyer R; Ketterling RP; Reichard KK
Am J Clin Pathol; 2020 Feb; 153(3):333-341. PubMed ID: 31671434
[TBL] [Abstract][Full Text] [Related]
34. Synchronous Diagnosis of
Shoyele O; Gupta G
Ann Clin Lab Sci; 2018 Nov; 48(6):790-796. PubMed ID: 30610052
[TBL] [Abstract][Full Text] [Related]
35. Therapy-related leukemia with Inv(16)(p13.1q22) and type D CBFB/MYH11 developing after exposure to irinotecan-containing chemoradiotherapy.
Akiyama H; Yamamoto M; Sakashita C; Umezawa Y; Kurosu T; Murakami N; Miura O
Intern Med; 2015; 54(6):651-5. PubMed ID: 25786458
[TBL] [Abstract][Full Text] [Related]
36. Molecular dissection of a hyper-aggressive CBFB-MYH11/FLT3-ITD-positive acute myeloid leukemia.
Lo Iudice G; De Bellis E; Savi A; Guarnera L; Massacci A; De Nicola F; Goeman F; Ottone T; Divona M; Pallocca M; Fanciulli M; Voso MT; Ciliberto G
J Transl Med; 2022 Jul; 20(1):311. PubMed ID: 35794567
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Mutation Profile in Acute Myeloid Leukemia Patients with
Qin W; Chen X; Shen HJ; Wang Z; Cai X; Jiang N; Hua H
Turk J Haematol; 2022 Jun; 39(2):84-93. PubMed ID: 35445594
[TBL] [Abstract][Full Text] [Related]
38. 3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant.
Tang G; Zou Y; Wang SA; Borthakur G; Toruner G; Hu S; Li S; Xu J; Medeiros LJ; Tang Z
Ann Hematol; 2022 Apr; 101(4):847-854. PubMed ID: 35184217
[TBL] [Abstract][Full Text] [Related]
39. Cryptic insertion of CBFB into MYH11 leading to a type D fusion in acute myeloid leukemia with normal karyotype.
Yamamoto K; Kurata K; Kitao A; Sakai R; Matsumoto S; Matsumoto H; Saegusa J; Yakushijin K; Minami H
Int J Lab Hematol; 2022 Feb; 44(1):e36-e39. PubMed ID: 34490987
[No Abstract] [Full Text] [Related]
40. Analytical study of
Sepúlveda-Robles O; Jiménez-Hernández E; Domínguez-Catzín V; Gómez-Flores E; Martín-Trejo JA; Flores-Lujano J; Torres-Nava JR; Núñez-Enríquez JC; De Ita M; Medina-Sanson A; Mata-Rocha M; Morales-Castillo BA; Bravata-Alcántara JC; Nájera-Cortés AS; Sánchez-Escobar N; Peñaloza-Gonzalez JG; Espinosa-Elizondo RM; Flores-Villegas LV; Amador-Sanchez R; Orozco-Ruiz D; Pérez-Saldívar ML; Velázquez-Aviña MM; Merino-Pasaye LE; Solís-Labastida KA; González-Ávila AI; Santillán-Juárez JD; Bekker-Méndez VC; Jiménez-Morales S; Rangel-López A; Rosas-Vargas H; Mejía-Aranguré JM
Front Pediatr; 2022; 10():946690. PubMed ID: 36452349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]